These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33071044)

  • 1. Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.
    Gabriele L; Fragale A; Romagnoli G; Parlato S; Lapenta C; Santini SM; Ozato K; Capone I
    Cytokine Growth Factor Rev; 2021 Apr; 58():66-74. PubMed ID: 33071044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
    Severa M; Diotti RA; Etna MP; Rizzo F; Fiore S; Ricci D; Iannetta M; Sinigaglia A; Lodi A; Mancini N; Criscuolo E; Clementi M; Andreoni M; Balducci S; Barzon L; Stefanelli P; Clementi N; Coccia EM
    PLoS Pathog; 2021 Sep; 17(9):e1009878. PubMed ID: 34473805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between SARS-CoV-2 and the type I interferon response.
    Sa Ribero M; Jouvenet N; Dreux M; Nisole S
    PLoS Pathog; 2020 Jul; 16(7):e1008737. PubMed ID: 32726355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals.
    Markmann AJ; Giallourou N; Bhowmik DR; Hou YJ; Lerner A; Martinez DR; Premkumar L; Root H; van Duin D; Napravnik S; Graham SD; Guerra Q; Raut R; Petropoulos CJ; Wrin T; Cornaby C; Schmitz J; Kuruc J; Weiss S; Park Y; Baric R; de Silva AM; Margolis DM; Bartelt LA
    mSphere; 2021 Aug; 6(4):e0027521. PubMed ID: 34431693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I Interferon Induction and Exhaustion during Viral Infection: Plasmacytoid Dendritic Cells and Emerging COVID-19 Findings.
    Greene TT; Zuniga EI
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities.
    Bienvenu LA; Noonan J; Wang X; Peter K
    Cardiovasc Res; 2020 Dec; 116(14):2197-2206. PubMed ID: 33063089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmacytoid dendritic cells during COVID-19: Ally or adversary?
    Van der Sluis RM; Holm CK; Jakobsen MR
    Cell Rep; 2022 Jul; 40(4):111148. PubMed ID: 35858624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
    Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication.
    Ishii H; Jounai K; Tsuji R; Ohshio K; Kaneda D; Okazaki M; Harada S; Fujiwara D; Matano T
    Biochem Biophys Res Commun; 2023 Jun; 662():26-30. PubMed ID: 37094430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2.
    Venet M; Ribeiro MS; Décembre E; Bellomo A; Joshi G; Nuovo C; Villard M; Cluet D; Perret M; Pescamona R; Paidassi H; Walzer T; Allatif O; Belot A; Trouillet-Assant S; Ricci EP; Dreux M
    Nat Commun; 2023 Feb; 14(1):694. PubMed ID: 36755036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19.
    Laurent P; Yang C; Rendeiro AF; Nilsson-Payant BE; Carrau L; Chandar V; Bram Y; tenOever BR; Elemento O; Ivashkiv LB; Schwartz RE; Barrat FJ
    Sci Immunol; 2022 Sep; 7(75):eadd4906. PubMed ID: 36083891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19.
    Spiering AE; de Vries TJ
    Front Immunol; 2021; 12():756262. PubMed ID: 34858409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.
    Onodi F; Bonnet-Madin L; Meertens L; Karpf L; Poirot J; Zhang SY; Picard C; Puel A; Jouanguy E; Zhang Q; Le Goff J; Molina JM; Delaugerre C; Casanova JL; Amara A; Soumelis V
    J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33533916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.
    Quarleri J; Delpino MV
    Cytokine Growth Factor Rev; 2021 Apr; 58():55-65. PubMed ID: 33608189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
    J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2.
    Agrawal S; Salazar J; Tran TM; Agrawal A
    Front Immunol; 2021; 12():739757. PubMed ID: 34745109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection.
    Cervantes-Barragan L; Vanderheiden A; Royer CJ; Davis-Gardner ME; Ralfs P; Chirkova T; Anderson LJ; Grakoui A; Suthar MS
    bioRxiv; 2021 May; ():. PubMed ID: 34013278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.